NCT01276275: Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel |
|
|
| Completed | N/A | 7200 | Europe | Risk of selected safety events | AstraZeneca | Bleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, Gout | 04/15 | 04/15 | | |
